Skip to main content
. 2021 Nov 24;12:752233. doi: 10.3389/fimmu.2021.752233

Figure 2.

Figure 2

SARS-CoV2 IgG (A–E) and neutralizing antibodies (F–J) decline over time since receiving the second dose of BNT162b2 (Pfizer–BioNTech) vaccine stratified by diabetes and hypertension status. The smooth relationships were derived from generalized additive models with penalized splines for duration (in days) and adjusted for age, gender, BMI, hypertension, diabetes status, comorbidity scores, and previous COVID-19 infections. Solid lines represent the effect estimates of change over time, while the shaded areas represent the 95% confidence intervals.